VYXEOS LIPOSOMAL
44MG/100MG INF PLV CSL 5
| SÚKL code | 0238217 |
|---|---|
| Name of the product | VYXEOS LIPOSOMAL |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | VYXEOS LIPOSOMAL |
| Supplement | 44MG/100MG INF PLV CSL 5 |
| Strenght | 44MG/100MG |
| Pharmaceutical form | Powder for concentrate for solution for infusion |
| Package | 5 |
| Route | Intravenous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance |
CYTARABINE (CYTARABINUM) DAUNORUBICIN (DAUNORUBICINUM) |
| ATC group | L01XY01 |
| ATC group name | CYTARABIN A DAUNORUBICIN |
Marketing authorisation information
| Registration Number | EU/1/18/1308/003 |
|---|---|
| Type of MA | Orphan medicinal products |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Jazz Pharmaceuticals Ireland Ltd, Dublin |
| MA Holder country | IRSKO |
cz